Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
PhosphoGam
AddedFeb 18, 2024
UpdatedJun 18, 2026
PhosphoGam

PhosphoGam

Raleigh-based medical organization, CED, accelerates business growth by connecting entrepreneurs with resources.

HQ
Raleigh, NC, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

PhosphoGam, founded in Raleigh, North Carolina, is a medical organization focused on advancing gamma/delta-T cell therapy. Their core mission is to harness the power of these unique immune cells to develop innovative treatments for various diseases. By leveraging cutting-edge research and technology, PhosphoGam aims to provide effective therapeutic solutions that improve patient outcomes and address unmet medical needs in the healthcare market.

Notable affiliated individuals include key researchers and medical professionals specializing in immunotherapy. PhosphoGam has garnered attention from investors interested in pioneering medical advancements, contributing to its growth and development. The organization is recognized for its potential impact on the field of cell therapy, positioning itself as a significant player in the biopharmaceutical industry.

PhosphoGam - Similar Companies

Phoenicis logo

Phoenicis

Gamma Therapeutics logo

Gamma Therapeutics

Pharmatrophix logo

Pharmatrophix

pharmatrophix.com

PhagePro logo

PhagePro

phageproinc.com

Macrophage Therapeutics logo

Macrophage Therapeutics

macrophagetx.com

Pathalys Pharma logo

Pathalys Pharma

pathalys.com

PeriphaGen logo

PeriphaGen

periphagen.com

Phoenix Biotechnology logo

Phoenix Biotechnology

Exodos Life Sciences logo

Exodos Life Sciences

exodosls.com

TheraCea Pharma logo

TheraCea Pharma

theracea.com

Petri Bio logo

Petri Bio

petribio.com

MitoChem Therapeutics logo

MitoChem Therapeutics

mitocheminc.com

Flag Therapeutics logo

Flag Therapeutics

Cellular Approaches logo

Cellular Approaches

OS Therapies logo

OS Therapies

ostherapies.com

PhosphoGam - Quick Facts

Who are PhosphoGam's competitors?

Companies similar to PhosphoGam include Phoenicis, Gamma Therapeutics, Pharmatrophix and PhagePro.

When was PhosphoGam founded?

PhosphoGam was founded in 2015.

Where is PhosphoGam's headquarters located?

PhosphoGam's headquarters is located in Raleigh, NC, US.

When was PhosphoGam's last funding round?

PhosphoGam's most recent funding round was for $250k (USD) in July 2018.

How much has PhosphoGam raised to-date?

As of Jul 31, 2018, PhosphoGam has raised a total of $250k (USD).

How many employees does PhosphoGam have?

PhosphoGam has 5 employees as of Feb 4, 2024.

PhosphoGam - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical
  • Therapy
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified